Retatrutide is an engineered single-peptide chain functioning as a triple co-agonist targeting GIP, GLP-1, and glucagon (GCGR) receptors. Laboratory evaluation profiles focus on its multi-receptor binding affinities and its influence on cellular energy homeostatic pathways in metabolic cell cultures.